James E Galvin Selected Research

Indicators and Reagents (Reagents)

1/2021

A Modified CAIDE Risk Score as a Screening Tool for Cognitive Impairment in Older Adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James E Galvin Research Topics

Disease

32	Dementia (Dementias) 05/2024 - 11/2005
26	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 07/2006
11	Cognitive Dysfunction 05/2024 - 07/2006
8	Parkinson Disease (Parkinson's Disease) 01/2021 - 02/2006
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2011 - 06/2004
3	Pain (Aches) 04/2023 - 01/2020
3	Lewy Body Disease (Lewy Body Dementia) 01/2023 - 01/2011
2	Disorders of Excessive Somnolence (Hypersomnia) 06/2024 - 02/2024
2	Pathologic Processes 05/2024 - 05/2012
2	Delirium 04/2023 - 01/2015
2	Inflammation (Inflammations) 01/2022 - 02/2010
2	Disease Progression 01/2016 - 05/2012
2	Hallucinations (Hallucination) 05/2013 - 11/2007
2	Amyloid Plaque 01/2011 - 12/2006
1	Parkinsonian Disorders (Parkinsonism) 01/2024
1	Essential Tremor (Essential Tremors) 01/2024
1	Endometriosis 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Sarcopenia 01/2020
1	Frailty 01/2020
1	Atherosclerosis 11/2019
1	Amyloid angiopathy 01/2011
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2011
1	Frontotemporal Dementia (Semantic Dementia) 01/2011
1	Prodromal Symptoms 01/2011
1	Stroke (Strokes) 02/2010
1	Huntington Disease (Huntington's Disease) 02/2010
1	Neurobehavioral Manifestations 11/2007
1	Neuroinflammatory Diseases 11/2007
1	Miyoshi myopathy 12/2006
1	Muscular Diseases (Myopathy) 12/2006

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2006
5	Amyloid (Amyloid Fibrils)IBA 11/2022 - 11/2007
5	Cholinesterase Inhibitors (Anticholinesterases)IBA 10/2020 - 11/2005
5	Proteins (Proteins, Gene)FDA Link 01/2011 - 06/2004
4	Apolipoproteins E (ApoE)IBA 01/2023 - 07/2013
4	Amyloid beta-PeptidesIBA 01/2023 - 04/2008
4	alpha-SynucleinIBA 04/2008 - 02/2006
3	Antipsychotic Agents (Antipsychotics)IBA 04/2023 - 11/2007
3	ApolipoproteinsIBA 09/2021 - 07/2013
3	Donepezil (Aricept)FDA LinkGeneric 01/2010 - 11/2005
2	Rivastigmine (Exelon)FDA LinkGeneric 01/2015 - 01/2014
2	Dopamine (Intropin)FDA LinkGeneric 02/2008 - 08/2006
1	RadiopharmaceuticalsIBA 01/2024
1	ioflupaneIBA 01/2024
1	Narcotics (Narcotic Analgesics)IBA 04/2023
1	Anti-Anxiety Agents (Anxiolytics)IBA 04/2023
1	Hypnotics and Sedatives (Sedatives)IBA 04/2023
1	A-Form DNA (A-DNA)IBA 01/2023
1	Leuprolide (Lupron)FDA LinkGeneric 01/2021
1	GoldIBA 01/2021
1	GonadotropinsIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Cholinesterases (Cholinesterase)IBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	luprolide acetate gel depot FDA Link 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	A-factor (Streptomyces)IBA 01/2016
1	Prednisolone (Predate)FDA LinkGeneric 07/2013
1	SilverIBA 11/2012
1	Triglycerides (Triacylglycerol)IBA 06/2012
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2012
1	Cholinergic Agents (Cholinergics)IBA 10/2011
1	SynucleinsIBA 01/2011
1	Prion ProteinsIBA 01/2011
1	Docosahexaenoic AcidsIBA 11/2010
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 11/2010
1	N2- ((2S)- 2- (3,5- difluorophenyl)- 2- hydroxyethanoyl)- N1- ((7S)- 5- methyl- 6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- L- alaninamideIBA 08/2008
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 08/2008
1	CurcuminIBA 04/2008
1	Galantamine (Galanthamine)FDA LinkGeneric 01/2008
1	DysferlinIBA 12/2006
1	Protein AggregatesIBA 06/2004
1	Messenger RNA (mRNA)IBA 06/2004

Therapy/Procedure

8	Therapeutics 06/2024 - 11/2005
8	Activities of Daily Living (ADL) 02/2024 - 08/2008
3	Precision Medicine 09/2023 - 01/2022
2	Long-Term Care 01/2023 - 01/2021
2	Institutionalization (Institutionalized Persons) 03/2021 - 12/2006
2	Drug Therapy (Chemotherapy) 06/2012 - 05/2012
1	Secondary Prevention 01/2021
1	Pain Management 01/2021
1	Patient Readmission 01/2015
1	Length of Stay 10/2010
1	Immunotherapy 11/2007